Tick-Borne Diseases in Dogs: Symptoms, Testing, Treatment, and Prevention

This article is educational and is not a substitute for veterinary diagnosis or treatment.

Owner Triage Summary: What You Need to Know Now

If your dog has a tick attached, or has had one recently, and is showing signs such as fever, lethargy, lameness, swollen lymph nodes, or unexplained bruising, seek veterinary attention promptly. A tick bite does not automatically mean your dog will become sick, and a positive antibody test does not confirm active disease. However, some tick-borne infections can progress rapidly and become life threatening. Emergency signs include pale gums, difficulty breathing, collapse, seizures, blood in urine or stool, or inability to walk. These require immediate veterinary assessment.

Removal of ticks is best done with fine-tipped tweezers or a tick removal tool, grasping the mouthparts close to the skin and pulling straight out without twisting. Do not apply heat, petroleum jelly, or other home remedies. Year-round, species-appropriate tick prevention prescribed by your veterinarian is the most effective way to reduce risk.

At a Glance: Major Tick-Borne Diseases of Dogs

Note: This table provides a framework but cannot capture all presentations. Coinfections are possible and can alter clinical signs.

Understanding Tick-Borne Disease: More Than a Bite

Ticks are arthropod vectors that feed on blood and, during feeding, can transmit bacteria, protozoa, or viruses. The risk of disease transmission depends on the tick species, the pathogen it carries, the duration of attachment, and the host's immune response. A tick bite alone, or a positive antibody test indicating exposure, does not establish active disease [1,12]. Many dogs are exposed and seroconvert without ever becoming clinically ill. Conversely, dogs can harbor infection for months or years before signs appear.

Geographic distribution of tick-borne pathogens is expanding due to climate change, wildlife movement, and human travel [14]. In North America, the range of Ixodes scapularis (the black-legged tick) has extended northward and inland, carrying Borrelia burgdorferi and Anaplasma phagocytophilum. In Europe, similar trends are seen with Ixodes ricinus and Dermacentor reticulatus. In Australia, Rhipicephalus sanguineus and Haemaphysalis longicornis are important vectors. Practitioners must be aware of regional prevalence and travel history.

Capable guidelines from the Companion Animal Parasite Council (CAPC) and other authoritative bodies emphasize that no single test is perfect for all stages of infection. Diagnosis depends on integrating history, physical examination, clinicopathologic findings, serology, polymerase chain reaction (PCR), and sometimes blood smear examination [11,12,13].

Clinical Patterns by Disease

Lyme Disease (Borreliosis)

Lyme disease is caused by the spirochete Borrelia burgdorferi and transmitted primarily by Ixodes ticks. In dogs, the most common clinical sign is intermittent lameness that shifts from leg to leg, often accompanied by fever, inappetence, and lethargy [5,8]. Lymphadenopathy is frequently present. Unlike humans, dogs rarely develop the classic erythema migrans "bull's-eye" rash, and when they do, it is often hidden by fur.

Renal involvement, termed Lyme nephritis, is a less common but serious complication that can lead to chronic kidney disease. Affected dogs may show protein-losing nephropathy, with signs such as polyuria, polydipsia, and peripheral oedema. The exact pathogenesis is incompletely understood but appears to be immune mediated [1,12].

In endemic regions, many dogs are seropositive without clinical disease. C6-based assays detect antibodies associated with natural exposure rather than antibodies produced by common Lyme vaccines, but a positive result still does not prove that current signs are caused by Lyme disease. Veterinarians interpret the result alongside the examination, exposure history, urinalysis, urine protein assessment when appropriate, and competing diagnoses. Detection of bacterial DNA in a suitable sample may support infection, but PCR sensitivity depends on the specimen and timing, so a negative result does not exclude disease [1,12].

Ehrlichiosis

Canine ehrlichiosis is caused by several species of Ehrlichia, with E. canis being the most significant worldwide [1,4]. The brown dog tick (Rhipicephalus sanguineus) is the principal vector. Three clinical phases are recognized: acute, subclinical, and chronic.

Acute disease may cause fever, lethargy, inappetence, and enlarged lymph nodes. Thrombocytopenia is a frequent laboratory finding [1,4]. Bleeding tendencies such as petechiae, ecchymoses, or epistaxis may occur, and some dogs develop ocular inflammation.

Subclinical infection: Some dogs appear normal while infection or antibody evidence persists. Laboratory abnormalities can remain, especially thrombocytopenia and hyperglobulinemia, but their presence and duration vary.

Chronic phase: In some dogs, especially those infected with E. canis, disease progresses to bone marrow suppression, severe thrombocytopenia, anemia, leukopenia, and potentially fatal hemorrhages. Neurologic signs (meningitis, ataxia) and ocular disease can develop.

Coinfection with Ehrlichia ewingii tends to cause a milder, self-limiting illness, but may exacerbate underlying conditions [1,3]. Ehrlichia chaffeensis, which is primarily a human pathogen, can also infect dogs and cause clinical signs similar to E. canis but is less common [1].

Anaplasmosis

Two species of Anaplasma cause disease in dogs: A. phagocytophilum (granulocytic anaplasmosis) and A. platys (cyclic thrombocytopenia) [5,9]. Both are transmitted by ticks, but their clinical presentations differ.

Granulocytic anaplasmosis (A. phagocytophilum) is reported in North America, Europe, and parts of Asia. Clinical signs are acute: fever, lethargy, inappetence, and lameness are the most common [5,8]. Lameness often involves multiple limbs and may be associated with polyarthritis. Neurologic signs (e.g., ataxia, seizures) are less common. Thrombocytopenia appears consistently. Some dogs develop immune-mediated hemolytic anemia (IMHA) as a complication [8].

Morulae (inclusion bodies) can sometimes be seen inside neutrophils on a blood smear, especially during the first few days of illness, but absence does not exclude infection. Coinfection with B. burgdorferi is frequent in endemic areas because they share the same tick vector. Dogs exposed to both pathogens may have more severe thrombocytopenia than those exposed to A. phagocytophilum alone [8].

Cyclic thrombocytopenia caused by A. platys produces recurring decreases in platelet count. Clinical signs may be subtle or absent, although bleeding can occur when thrombocytopenia is marked or another disorder is present. PCR and, less often, identification of platelet inclusions can contribute to diagnosis [9].

Babesiosis

Canine babesiosis is a protozoal disease caused by multiple species of Babesia, which are obligate intraerythrocytic parasites [2,6,7]. Transmission is primarily through tick bites, but blood transfusion and transplacental transmission also occur. Geographic distribution of species varies: B. canis is common in Europe; B. vogeli in warmer climates worldwide; B. gibsoni in Asia and increasingly in the United States, often associated with fighting breeds; B. conradae in the southwestern US; and B. vulpes (formerly B. microti-like) in Europe [2,6].

Clinical signs range from mild to peracute, fatal disease. Classic signs include fever, lethargy, anemia (with pale mucous membranes), icterus, splenomegaly, and pigmenturia (dark urine from hemoglobinuria). The severity depends on host immunity and Babesia species. Clinical complications include acute kidney injury, acute respiratory distress syndrome, disseminated intravascular coagulation, pancreatitis, and hypoglycemia [7,10].

The most common laboratory findings are hemolytic anemia (regenerative or non-regenerative depending on stage), thrombocytopenia, and increased liver enzymes. Hyperbilirubinemia and bilirubinuria are common.

Rocky Mountain Spotted Fever

RMSF is caused by Rickettsia rickettsii, a bacterium that infects endothelial cells, leading to vasculitis [9]. It is transmitted by Dermacentor ticks in the Americas. The disease is potentially fatal if not treated early.

Clinical disease can progress quickly. Findings may include fever, petechiae, limb or facial edema, enlarged lymph nodes, cough, and neurologic abnormalities such as altered mentation, ataxia, or seizures. Visible skin lesions may be difficult to appreciate beneath hair. Laboratory findings can include thrombocytopenia, white-cell changes, elevated liver enzymes, and hypoalbuminemia [9].

Diagnosis is often presumptive based on clinical signs and response to therapy, as serology may be negative early in infection. PCR on skin biopsy or EDTA blood can confirm infection but is not widely available [9].

Hepatozoonosis

Hepatozoonosis is unique among tick-borne diseases because transmission occurs through ingestion of ticks (not a bite). Dogs acquire Hepatozoon by eating infected ticks (often Rhipicephalus sanguineus for H. canis, or Amblyomma maculatum for H. americanum). This can happen when dogs groom themselves or eat ticks from the environment.

H. canis (Old World) tends to cause a mild to moderate illness with fever, lethargy, and ocular discharge. H. americanum (New World) is more severe, causing a debilitating myositis, periosteal bone proliferation (new bone formation along long bones), muscle wasting, and a purulent ocular discharge. Diagnosis is by detection of gamonts in neutrophils on blood smear (especially for H. canis) or muscle biopsy for H. americanum. PCR is confirmatory [11,12].

Geographic Distribution and Expanding Ranges

The geographic range of tick vectors and their pathogens is dynamic. In North America, Ixodes scapularis has expanded from the Northeast and Upper Midwest into the Mid-Atlantic and parts of Canada. Dermacentor variabilis (American dog tick) and Amblyomma americanum (Lone Star tick) are also spreading. CAPC maintains up-to-date prevalence maps [11,14].

In Europe, Ixodes ricinus is the primary vector for Lyme and anaplasmosis, while Dermacentor reticulatus and Rhipicephalus sanguineus transmit Babesia canis and E. canis respectively [3,6]. Southern Europe, the Mediterranean, and continental Europe all show high prevalence.

In Australia, the arrival and spread of E. canis has increased the importance of brown dog tick exposure. Tick paralysis is a separate tick-associated emergency and should not be confused with the infectious syndromes covered here.

Travel and relocation of dogs are major risk factors. A dog that visited an endemic area may have an infection that is not yet patent. Blood donor screening is essential to prevent transfusion-transmitted babesiosis and ehrlichiosis [1,2].

Diagnostic Approach: Testing Beyond the Antibody Result

No single test is sufficient to rule out all tick-borne infections. The following are used in combination:

Blood Smear Examination

Direct visualization of organisms can provide a rapid diagnosis but has low sensitivity. Morulae of A. phagocytophilum in neutrophils are seen only early in infection. Babesia organisms may be visible in erythrocytes, but parasitemia can be low. Hepatozoon gamonts are easier to find in buffy coat smears. Inability to find organisms does not exclude infection [4,7].

Complete Blood Count and Chemistry

Thrombocytopenia is the most consistent abnormality in many tick-borne diseases, especially ehrlichiosis and anaplasmosis [8]. Anemia (hemolytic for babesiosis, non-regenerative for chronic ehrlichiosis) is common. Leukocyte counts vary: leukopenia may be seen in acute RMSF and ehrlichiosis; leukocytosis in chronic ehrlichiosis and hepatozoonosis. Hyperglobulinemia (especially in chronic ehrlichiosis) and elevated liver enzymes are frequent [1,10].

Serology

Tests detect antibodies against specific pathogens. A positive result indicates exposure or an immune response, not necessarily active clinical disease. In endemic areas, healthy dogs may be seropositive. C6-based Lyme assays help separate natural exposure from responses to common Lyme vaccines, but they do not identify the cause of illness on their own. Antibodies may be absent early, so veterinarians may use paired samples collected at clinically appropriate times when a change in titer would aid interpretation [1,5].

Polymerase Chain Reaction (PCR)

PCR detects pathogen DNA in blood, joint fluid, or tissue and can help distinguish organisms that serology cannot separate. Its performance varies by pathogen, disease stage, specimen, and prior treatment. PCR is particularly useful for identifying Babesia and for species-level questions involving Ehrlichia or Anaplasma, but a negative result does not completely exclude infection because the sampled material may contain little or no detectable DNA [2,7].

Coinfection Testing

Dogs can be infected with multiple tick-borne pathogens simultaneously. Coinfection is plausible when vectors, geography, and travel exposures overlap. Veterinarians select targeted or panel testing according to the clinical pattern and local epidemiology; testing every organism in every dog can create incidental findings without clarifying the cause of illness [8,12].

Blood Donor Screening

Many of these pathogens can be transmitted via blood transfusion. Blood donor dogs should be screened by PCR for Babesia, Ehrlichia, Anaplasma, and Rickettsia, and ideally should be from areas with low tick prevalence. Serologic screening alone is insufficient because infected dogs may be seronegative [2,13].

Treatment Principles: Veterinarian-Selected Therapy

Treatment must be tailored to the individual dog, the specific pathogen, and the severity of clinical signs. Medication choice, dosing, duration, and monitoring require a veterinarian; owners should not use leftover antibiotics or medicate a dog solely because a tick was found.

• Antibiotic therapy: Tetracycline-class therapy is commonly used for several bacterial tick-borne infections. The drug, dose, duration, contraindications, and response assessment belong to the treating veterinarian because these differ by organism and patient [1,5].
• Antiprotozoal therapy: For babesiosis, multiple drugs are used depending on species, including imidocarb dipropionate, atovaquone azithromycin combination, and others. Selection is based on species identification because not all Babesia respond to the same drug. Treatment may not eliminate infection; some dogs become chronic carriers [2,6,7].
• Supportive care: Fluid therapy, blood transfusions for severe anemia, antiemetics, hepatoprotectants, and management of disseminated intravascular coagulation may be necessary. Renal protection is critical in Lyme nephritis.
• Monitoring: Rechecking blood cell counts, serology, and PCR after treatment is important to document resolution of clinical signs and to detect relapse. Chronic carriers may require long-term monitoring.

Important: Clinical remission does not always mean elimination of infection. For ehrlichiosis and anaplasmosis, some dogs remain infected despite treatment and can later relapse, especially if immunocompromised [1]. Similarly, some Babesia infections become chronic carriers.

Prevention: Year-Round, Species-Appropriate Control

Prevention is multilayered and must include vector control, environmental management, and avoidance of tick habitats.

Tick Prevention Products

Numerous topical spot-ons, oral chews, collars, and sprays are available. CAPC recommends year-round control because tick activity is not confined to warm weather. Product selection should account for the dog's health, lifestyle, household species, swimming or bathing, and local ticks. Some products repel ticks; others kill after contact or attachment. Products labeled only for dogs can be dangerous to cats, and human repellents should not be applied to pets unless a veterinarian and the product label specifically support that use.

Environmental Management

Outdoor habitat changes may reduce exposure, but no yard can be certified tick-free. Mowing frequently used areas, managing leaf litter and brush, discouraging wildlife access without harming wildlife, and keeping dogs out of dense edge vegetation can complement host-targeted prevention. Indoor or kennel control is a different problem. Brown dog ticks can complete their life cycle in buildings, and CAPC warns that established infestations may take months to control and often require consistent treatment of pets plus a licensed pest-control professional [11]. Owners should not apply agricultural, livestock, human, or environmental pesticides to a dog unless the label specifically authorizes that use.

Tick Checks and Prompt Removal

Check a dog after outdoor activity even when an effective preventive is used. Ticks may crawl on the coat before attaching, and products differ in whether they repel, kill after contact, or kill after attachment. Examine around the ears, eyelids, lips, neck, feet, between toes, armpits, groin, and beneath collars or harnesses. A long or dense coat should be separated down to the skin. A new lump is not automatically a tick, so use adequate light rather than pulling blindly.

For an attached tick, CAPC advises using forceps or a commercial tick-removal device while avoiding contact with tick contents, ideally with gloves [11]. Follow the device instructions and grasp according to its design. Do not burn the tick, coat it in petroleum jelly or essential oil, crush it against the dog, or twist with bare fingers. Clean the site and hands afterward. If mouthparts appear to remain, the site becomes increasingly red, swollen, painful, or draining, or the dog resists safe handling, ask a veterinary team for help. Digging deeply at the skin can create more trauma than the retained fragment.

Removal is worthwhile, but it cannot establish whether a pathogen was transmitted. Transmission timing differs among tick-pathogen pairs, and owners usually cannot determine attachment duration accurately from tick size. Conversely, finding no tick does not exclude exposure because ticks may detach or be overlooked. Record the date, approximate location, travel history, preventive product, and any changes in the dog. A photograph beside a ruler may assist identification. If a veterinarian or laboratory requests the tick, place it in a secure container as instructed; do not assume that testing the tick diagnoses the dog.

What a Positive Screening Test Means

Many point-of-care screening tests detect antibodies rather than the organism itself. A positive antibody result shows that the immune system has recognized a target antigen, subject to the test’s specificity and possible cross-reaction. It does not by itself prove that the organism is currently causing fever, lameness, low platelets, kidney injury, or another sign. Subclinical exposure is common for several agents, and antibodies can persist after clinical recovery [1,11,12]. The veterinarian therefore considers the result with the physical examination, complete blood count, chemistry and urine findings, geography, travel, prevention history, and previous results.

This distinction prevents two opposite errors. Treating every antibody-positive, clinically well dog as though it has active disease may expose dogs to medication without establishing a diagnosis. Dismissing a compatible illness because a screening test is negative may also be unsafe. Antibodies may not yet be detectable early in infection, and test panels cover only selected organisms. CAPC specifically recommends combining clinical signs, serology, PCR, and hematology when evaluating ehrlichiosis and anaplasmosis rather than using one result in isolation [11].

Some Lyme assays detect antibodies to antigens associated with natural infection rather than common vaccine responses. That helps answer whether exposure has occurred, but it still does not convert a positive result into a diagnosis of active Lyme disease. Quantitative or follow-up testing may contribute to a veterinarian’s assessment in selected cases, particularly when urine protein loss or compatible joint signs are present, but no antibody value should be interpreted without the dog’s clinical context [1,12].

What PCR Can and Cannot Answer

PCR looks for pathogen nucleic acid in the submitted sample and can help distinguish organisms that antibody tests group together. A positive result can be strong evidence of infection when sampling, assay specificity, and clinical context align. It still does not automatically prove that every sign is caused by that organism, especially in a dog with coinfection or another disease.

A negative PCR is not a universal rule-out. Organisms may circulate intermittently or below the assay’s detection limit, the sampled tissue may not contain the organism, prior antimicrobial treatment may suppress detection, and laboratories differ in validated methods. CAPC notes both false-positive and apparent false-negative mechanisms for ehrlichial and anaplasmal PCR and advises early sampling before antimicrobial therapy when feasible [11]. That guidance is for the veterinary team; owners should not delay treatment of a seriously ill dog to pursue an ideal sample.

Why Serology May Need Paired Samples

For some acute infections, comparison of antibody titers collected at different times can be more informative than a single measurement. A meaningful rise may support recent infection when interpreted with compatible illness, while a stable titer can reflect older exposure. The necessary interval, laboratory method, and interpretation depend on the organism. Starting treatment may be appropriate before the second sample in a clinically concerning case, so paired testing is not a justification for watchful waiting without veterinary supervision.

Cross-reactivity is another concern. Antibodies to related Ehrlichia species may not identify the infecting species, and spotted-fever-group rickettsial serology can react across related organisms. Species-level differentiation may require a validated molecular assay, epidemiologic context, or both [1,4,9]. The absence of one perfect test across organisms and disease stages means that clinical synthesis matters more than any isolated result.

Cross‑reactivity is another concern. Antibodies to Ehrlichia canis may cross‑react with E. chaffeensis and E. ewingii, making species‑level differentiation difficult without PCR [1,4]. Similarly, serologic tests for Rickettsia rickettsii can cross‑react with other spotted fever group rickettsiae, which are generally non‑pathogenic in dogs but complicate interpretation [9].

The absence of one perfect test across organisms and disease stages means that clinical interpretation matters more than any isolated result. Compatible signs, blood and urine findings, exposure history, serology, PCR, microscopy, and change over time may contribute in different combinations [11,12]. Treating every antibody-positive dog can expose dogs to medication without establishing the cause of illness, while overreliance on one negative PCR can delay investigation of a plausible infection.

Owner Observation: What to Watch and How to Prepare for a Veterinary Visit

Before presenting to the veterinarian, owners can collect valuable information that speeds diagnosis and reduces unnecessary testing. The first step is to document the tick exposure history: when and where the tick was found, how long it had been attached (a rough estimate based on engorgement size can help), and how it was removed. If possible, the tick should be saved in a sealed plastic bag in the refrigerator for potential species identification, as the vector can guide the differential diagnosis [11,14].

Owners can keep a log of observed signs, noting onset, progression, and fluctuations. For lameness, record which leg is affected and whether the problem shifts. Note changes in appetite, activity, breathing, urine color, unexplained bleeding, or small red skin spots. Feeling warm is not a reliable way to diagnose fever, and owners should not delay care while attempting measurements that are unfamiliar or stressful for the dog.

At the veterinary visit, useful information includes recent and historical travel, outdoor environments, current tick-prevention product and last application, previous positive tests, transfusion or blood-donor history, and all medications or supplements. The relevant look-back period depends on the organism and clinical presentation.

Some reference-laboratory tests are not immediate. A veterinarian may begin treatment when the consequences of waiting outweigh the uncertainty, while continuing to evaluate other causes. Owners should follow the written plan, report worsening signs or suspected adverse effects, and avoid changing or stopping medication without guidance [1].

Prevention in Depth: Product Selection, Resistance, and Lifecycle Management

Tick prevention products are not all equivalent, and the choice should be individualized to the dog’s lifestyle and local tick fauna. Oral isoxazoline chews (e.g., afoxolaner, fluralaner, sarolaner) provide rapid killing of attached ticks and are highly effective against Ixodes, Dermacentor, and Rhipicephalus species. They do not repel ticks; therefore, a tick may still attach and feed briefly before dying, which theoretically could allow some pathogen transmission [11]. Topical products containing permethrin combined with fipronil or imidacloprid offer repellent activity and are useful for dogs that spend time in high‑risk habitats. However, permethrin is highly toxic to cats, so households with both species must use caution. Collars containing flumethrin or deltamethrin provide long‑lasting protection but may be less convenient for some owners [11].

Loss of control can reflect missed or late applications, incorrect use, bathing effects on some topical products, environmental infestation, or a product that does not match local tick pressure. Owners should have the veterinary team investigate the cause rather than rotating or combining products independently. CAPC recommends consistent year-round control because activity varies by tick species and brown dog ticks can persist indoors [11,14].

Environmental management is particularly important for brown dog tick infestations because these ticks can complete their life cycle indoors. Vacuuming and laundering compatible materials may support control, but environmental pesticides can harm people, pets, fish, and other animals if misused. Severe or persistent infestations warrant coordinated veterinary and licensed pest-control advice, with exact label directions and pet-exclusion instructions followed [11].

For dogs with a history of recurrent tick attachment despite product use, the veterinarian should reassess the product choice, ensure proper dosing based on weight, and check for owner compliance. Bathing or swimming too soon after topical application can reduce efficacy. Some dogs may require a product switch or addition of a tick collar to achieve adequate protection.

Prognosis Nuances and Special-Population Considerations

Prognosis varies by pathogen, disease severity, treatment timing, immune status, and concurrent disease. Young or older dogs may have less reserve for anemia, dehydration, kidney injury, or systemic inflammation, but age alone does not determine the course [5,7,8,10].

Selected reports describe breed patterns for particular complications, but referral populations, geography, travel, kennel history, and exposure can distort associations. Breed should not be used to diagnose or exclude infection. Concurrent kidney, endocrine, immune-mediated, or neoplastic disease may change the differential diagnosis, treatment risk, and monitoring plan [1,2,12].

Chronic E. canis infection with bone-marrow suppression carries a guarded prognosis and may require intensive supportive care. Historical reports of breed associations should be interpreted cautiously and should not outweigh exposure, examination, and laboratory evidence [1,4].

For babesiosis caused by B. gibsoni, eradication is difficult, and many dogs become lifelong carriers despite treatment [2,7]. Relapses can occur during periods of stress or immunosuppression. Owners should be informed that such dogs should not be used as blood donors because of the risk of transfusion‑transmitted infection [13].

Follow-up is individualized. Repeat examination, blood counts, chemistry, urinalysis, protein assessment, serology, or PCR may be appropriate depending on the organism, initial abnormalities, response, relapse risk, and whether the dog is a blood donor. Neither persistent antibodies nor one PCR result should trigger automatic retreatment without clinical interpretation [1,12].

Special Populations: Puppies, Senior Dogs, and Immunocompromised Patients

Puppies have less physiologic reserve for severe anemia or systemic illness. Tick-prevention products have product-specific age and weight restrictions, so a veterinarian should match the label to the individual puppy. Home remedies and products intended for another species are unsafe substitutes.

Senior dogs often have concurrent kidney, cardiac, endocrine, gastrointestinal, or musculoskeletal disease that can mimic signs or complicate treatment. The veterinarian should review organ function, hydration, current medication, and interaction risk before selecting therapy. Owners should not add human pain relievers or leftover veterinary medication.

Immunocompromised patients, whether due to disease (e.g., lymphoma, ehrlichiosis itself) or medication (e.g., glucocorticoids, chemotherapy), are at increased risk of reactivation of latent infections. For example, a dog that was previously infected with E. canis and then placed on high‑dose corticosteroids may develop a recrudescence of thrombocytopenia and fever [1,4]. Similarly, dogs with babesiosis may relapse during chemotherapy. Veterinarians should consider screening for tick‑borne disease before starting immunosuppressive therapy in dogs from endemic areas [1,12].

Blood donor screening is important because several vector-borne organisms can be transmitted through blood. Donor programs should use current transfusion-medicine guidance and laboratory methods selected for the donor's geography and travel history. Prior exposure does not automatically determine eligibility, but it must be assessed by the supervising veterinarian [2,13].

Household and One Health Implications

A dog with Lyme disease, ehrlichiosis, anaplasmosis, or RMSF is not ordinarily contagious through touching, sharing bowls, saliva, or living in the same room. The household concern is shared vector exposure. A tick can enter on a dog, a person, clothing, outdoor equipment, or another animal, and brown dog ticks can establish indoor populations. Finding a tick or diagnosing a vector-borne infection in one household member should prompt a practical review of prevention and exposure for the whole household, without treating the dog as a direct infection hazard [11,13].

Dogs may act as sentinels for local tick activity. A positive canine screening result does not prove that a person has been infected, and veterinary test results cannot diagnose a human illness. People who develop concerning symptoms after possible tick exposure should contact a human healthcare professional and describe the exposure. Pet owners should not take a dog's antibiotics, apply veterinary ectoparasiticides to themselves, or use a human medical test to make decisions about the dog.

Tick checks are most useful when they are routine and gentle. Examine the head, ears, neck, armpits, groin, feet, and areas beneath collars or harnesses after outdoor activity. Long coats may need to be separated with the fingers or a comb. Prompt removal reduces feeding time and provides an opportunity to inspect the attachment site, but it does not guarantee that transmission did or did not occur. Crushing a tick with bare fingers or handling it near the face creates avoidable exposure to tick contents.

Households with both dogs and cats need special caution because some dog products are hazardous to cats. Keep animals separated exactly as the label directs after application, store products in their original packaging, and record which animal received which product. If a cat contacts a dog-only product or develops tremors, drooling, weakness, or unusual behavior after possible exposure, contact a veterinarian or animal poison service promptly.

Environmental control should match the tick involved. Yard modification may reduce encounters with ticks associated with vegetation and wildlife, while an indoor brown dog tick infestation usually requires coordinated treatment of every susceptible dog and the premises. More pesticide is not necessarily more effective. Combining products, treating rooms while pets remain inside, or applying agricultural chemicals without label authorization can create poisoning risks. Veterinary guidance and licensed pest-control support help align animal treatment, environmental treatment, and follow-up [11].

Frequently Asked Questions

1. Can a dog with a positive tick disease test infect other dogs or humans? Ordinary contact with a positive dog does not transmit Lyme disease, ehrlichiosis, anaplasmosis, or RMSF. People and dogs can share exposure to infected ticks. Some Babesia organisms can also spread through direct blood exposure, transfusion, or from dam to offspring, depending on the organism.

2. I found a tick on my dog but there are no symptoms. Should I test for tick diseases? Remove the tick promptly and record where exposure occurred. Testing immediately after an uncomplicated bite may be too early for some methods, but timing depends on the tick, region, signs, and the dog's health. Ask a veterinarian when testing or monitoring is appropriate.

3. How soon after a tick bite do symptoms appear? Timing varies by organism and host. Some illnesses appear relatively soon after exposure, whereas Lyme-associated signs may be delayed, and many exposed dogs never develop recognizable disease. New illness after a known or possible tick exposure deserves veterinary context rather than reliance on one timeline.

4. Can tick-borne diseases be cured completely? Many dogs recover clinically, but microbiologic clearance and relapse risk differ by organism. Some Babesia and Ehrlichia infections can persist despite improvement. Follow-up should be based on the diagnosis, original abnormalities, and the dog's response.

5. Is there a vaccine for tick-borne diseases in dogs? Lyme vaccines are available in some regions and may be recommended after an individual risk assessment. They do not prevent tick attachment or protect against the other infections covered here, so consistent tick control remains essential.

6. My dog has been treated for Lyme disease but still tests positive. Why? Antibodies can persist after clinical improvement, so a positive serology alone does not prove treatment failure or establish a need for retreatment. C6-based testing reflects natural exposure rather than common vaccine antibodies, but it still requires clinical interpretation.

7. Are there any home remedies that can treat tick-borne diseases in dogs? No. Home remedies such as garlic, essential oils, or herbal supplements have no proven efficacy against these pathogens and may be toxic. All tick-borne illnesses require veterinary diagnosis and prescription treatment.

8. How do I choose the best tick prevention product for my dog? There is no single best product for every dog. Your veterinarian will consider your dog's breed, weight, health status, lifestyle, and local tick species. Many safe and effective oral and topical products are available. Never use a product intended for another species.

Related Veterinary Guides

• Tick Prevention for Dogs
• Lyme Disease in Dogs
• Lyme Vaccine for Dogs
• Kidney Disease in Dogs
• Heartworm Prevention for Dogs

References

[1] Diniz PPVP, Moura de Aguiar D. Ehrlichiosis and Anaplasmosis: An Update. The Veterinary clinics of North America. Small animal practice. 2022. https://pubmed.ncbi.nlm.nih.gov/36336419/

[2] Dear JD, Birkenheuer A. Babesia in North America: An Update. The Veterinary clinics of North America. Small animal practice. 2022. https://pubmed.ncbi.nlm.nih.gov/36336417/

[3] Sainz Á, Roura X, Miró G, Estrada-Peña A et al. Guideline for veterinary practitioners on canine ehrlichiosis and anaplasmosis in Europe. Parasites vectors. 2015. https://pubmed.ncbi.nlm.nih.gov/25649069/

[4] Little SE. Ehrlichiosis and anaplasmosis in dogs and cats. The Veterinary clinics of North America. Small animal practice. 2010. https://pubmed.ncbi.nlm.nih.gov/20933140/

[5] Carrade DD, Foley JE, Borjesson DL, Sykes JE. Canine granulocytic anaplasmosis: a review. Journal of veterinary internal medicine. 2009. https://pubmed.ncbi.nlm.nih.gov/19761477/

[6] Solano-Gallego L, Sainz Á, Roura X, Estrada-Peña A et al. A review of canine babesiosis: the European perspective. Parasites vectors. 2016. https://pubmed.ncbi.nlm.nih.gov/27289223/

[7] Ayoob AL, Hackner SG, Prittie J. Clinical management of canine babesiosis. Journal of veterinary emergency and critical care (San Antonio, Tex.: 2001). 2010. https://pubmed.ncbi.nlm.nih.gov/20230437/

[8] Mazepa AW, Kidd LB, Young KM, Trepanier LA. Clinical presentation of 26 anaplasma phagocytophilum-seropositive dogs residing in an endemic area. Journal of the American Animal Hospital Association. 2010. https://pubmed.ncbi.nlm.nih.gov/21041333/

[9] Atif FA, Mehnaz S, Qamar MF, Roheen T et al. Epidemiology, Diagnosis, and Control of Canine Infectious Cyclic Thrombocytopenia and Granulocytic Anaplasmosis: Emerging Diseases of Veterinary and Public Health Significance. Veterinary sciences. 2021. https://pubmed.ncbi.nlm.nih.gov/34941839/

[10] Köster LS, Lobetti RG, Kelly P. Canine babesiosis: a perspective on clinical complications, biomarkers, and treatment. Veterinary medicine (Auckland, N.Z.). 2015. https://pubmed.ncbi.nlm.nih.gov/30155438/

[11] CAPC Ticks Guideline. https://capcvet.org/guidelines/ticks/

[12] CAPC Ehrlichia and Anaplasma Guideline. https://capcvet.org/guidelines/ehrlichia-spp-and-anaplasma-spp/

[13] CAPC General Guidelines for Dogs and Cats. https://capcvet.org/guidelines/general-guidelines/

[14] CAPC 2026 Parasite Forecast. https://capcvet.org/articles/2026-annual-pet-parasite-forecasts/